The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy

Canadian Journal of Cardiology

Volumn 21, Issue 11, 2005, Pages 915-920

  Evrengul, Harun ^a,c   Celik, Turgay ^b   Tanriverdi, Halil ^a   Kaftan, Asuman ^a   Dursunoglu, Dursun ^a   Kilic, Mustafa ^a  

^a PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c NONE   (Turkey)

Author keywords

Acute myocardial infarction; Preinfarction angina; Reperfusion time; Thrombolytic therapy

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; METOPROLOL; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART FAILURE; ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; CORONARY REPERFUSION; FEMALE; FIBRINOLYTIC THERAPY; FREQUENCY ANALYSIS; HEART ATRIUM FIBRILLATION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RISK FACTOR; ST SEGMENT; THORAX PAIN;

AGE FACTORS; AGED; ANGINA, UNSTABLE; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 27744564367     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902.
2. Lincoff AM, Topol EJ. Illusion of reperfusion: Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation 1993;88:1361-74.
3. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-22. (Erratum in 1994;330:516)
4. Jang IK, Gold HK, Ziskind AA, et al. Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis. Circulation 1989;79:920-8.
5. Loscalzo J, Weinfeld M, Fless GM, Scanu AM. Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis 1990;10:240-5.
6. Braunwald E. Morning resistance to thrombolytic therapy. Circulation 1995;91:1604-6.
7. Andreotti F, Pasceri V, Hackett DR, Davies GJ, Haider AW, Maseri A. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med 1996;334:7-12.
8. Ottani F, Galvani M, Ferrini D, et al. Prodromal angina limits infarct size. A role for ischemic preconditioning. Circulation 1995;91:291-7.
9. Anzai T, Yoshikawa T, Asakura Y, et al. Preinfarction angina as a major predictor of left ventricular function and long-term prognosis after a first Q wave myocardial infarction. J Am Coll Cardiol 1995;26:319-27.
10. Kloner RA, Yellon D. Does ischemic preconditioning occur in patients? J Am Coll Cardiol 1994;24:1133-42.
11. Pierard LA, Dubois C, Smeets JP, Boland J, Carlier J, Kulbertus HE. Prognostic significance of angina pectoris before first acute myocardial infarction. Am J Cardiol 1988;61:984-7.
12. Cortina A, Ambrose JA, Prieto-Granada J, et al. Left ventricular function after myocardial infarction: Clinical and angiographic correlations. J Am Coll Cardiol 1985;5:619-24.
13. Lown B, Wolf M. Approaches to sudden death from coronary heart disease. Circulation 1971;44:130-42.
14. Austen WG, Edwards JE, Frye RL, et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975;51(4 suppl):5-40.
15. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985;312:932-6.
16. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985;5:587-92.
17. Tomai F, Crea F, Chiariello L, Gioffre PA. Ischemic preconditioning in humans: Models, mediators, and clinical relevance. Circulation 1999;100:559-63.
18. Przyklenk K, Whittaker P. Brief antecedent ischemia enhances recombinant tissue plasminogen activator-induced coronary thrombolysis by adenosine-mediated mechanism. Circulation 2000;102:88-95.
19. Airaksinen KE, Huikuri HV. Antiarrhythmic effect of repeated coronary occlusion during balloon angioplasty. J Am Coll Cardiol 1997;29:1035-8.
20. Evrengul H, Kayikcioglu M, Can L, Payzin S, Kultursay H. Effect of pre-infarction angina on ventricular late potentials in patients with acute myocardial infarction and successful thrombolysis. Acta Cardiol 2003;58:295-301.
21. Parratt J, Vegh A. Pronounced antiarrhythmic effects of ischemic preconditioning. Cardioscience 1994;5:9-18. (Erratum in 1994;5:preceding 63)
22. Barber MJ. Effect of time interval between repeated brief coronary artery occlusions on arrhythmia, electrical activity and myocardial blood flow. J Am Coll Cardiol 1983;2:699-705.
23. Yellon DM, Baxter GF, Garcia-Dorado D, Heusch G, Sumeray MS. Ischaemic preconditioning: Present position and future directions. Cardiovasc Res 1998;37:21-33.
24. Przyklenk K, Kloner RA. Ischemic preconditioning: Exploring the paradox. Prog Cardiovasc Dis 1998;40:517-47.
25. Lasley RD, Konyn PJ, Hegge JO, Mentzer RM Jr. Effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size. Am J Physiol 1995;269:H1460-6.
26. Kitakaze M, Hori M, Sato H, et al. Endogenous adenosine inhibits platelet aggregation during myocardial ischemia in dogs. Circ Res 1991;69:1402-8.
27. Hackett D, Davies G, Chierchia S, Maseri A. Intermittent coronary occlusion in acute myocardial infarction: Value of combined thrombolytic and vasodilator therapy. N Engl J Med 1987;317:1055-9.
28. Davies GJ, Chierchia S, Maseri A. Prevention of myocardial infarction by very early treatment with intracoronary streptokinase. Some clinical observations. N Engl J Med 1984;311:1488-92.
29. Kagen L, Scheidt S, Butt A. Serum myoglobin in myocardial infarction: The "staccato phenomenon". Is acute myocardial infarction in man an intermittent event? Am J Med 1977;62:86-92.
30. Falk E. Unstable angina with fatat outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embotization culminating in total vascular occlusion. Circulation 1985;71:699-708.
31. Doevendans PA, Gorgels AP, van der Zee R, Partouns J, Bar FW, Wellens HJ. Electrocardiographic diagnosis of reperfusion during thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1995;75:1206-10.
32. Hohnloser SH, Zabel M, Kasper W, Meinertz T, Just H. Assessment of coronary artery patency after thrombolytic therapy: Accurate prediction utilizing the combined analysis of three noninvasive markers. J Am Coll Cardiol 1991;18:44-9.
33. Salazar AE. Experimental myocardial infarction. Induction of coronary thrombosis in the intact closed-chest dog. Circ Res 1961;9:1351-6.
34. Kloner RA, Shook T, Przyklenk K, et al. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation 1995;91:37-45.
35. Abete P, Ferrara N, Cacciatore F, et al. Angina-induced protection against myocardial infarction in adult and elderly patients: A loss of preconditioning mechanism in the aging heart? J Am Coll Cardiol 1997;30:947-54.
36. Barbash GI, White HD, Modan M, Van de Werf F. Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. J Am Coll Cardiol 1992;20:36-41.
37. Gheeraert PJ, Henriques JP, De Buyzere ML, De Pauw M, Taeymans Y, Zijlstra F. Preinfarction angina protects against out-of-hospital ventricutar fibrillation in patients with acute occlusion of the left coronary artery. J Am Coll Cardiol 2001;38:1369-74.
38. Pasceri V, Lanza GA, Patti G, Pedrotti P, Crea F, Maseri A. Preconditioning by transient myocardial ischemia confers protection against ischemia-induced ventricular arrhythmias in variant angina. Circulation 1996;94:1850-6.
39. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22. (Erratum in 1994;343:742)
40. Newby LK, Rutsch WR, Califf RM, et al; GUSTO-1 Investigators. Time from symptom onset to treatment and outcomes after thrombolytic therapy. J Am Coll Cardiol 1996;27:1646-55.
41. Zijlstra F, Patel A, Jones M, et al. Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J 2002;23:550-7.
42. Langer A, Freeman MR, Armstrong PW. ST segment shift in unstable angina: Pathophysiology and association with coronary anatomy and hospital outcome. J Am Coll Cardiol 1989;13:1495-502.
43. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-8.
44. van't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F; Zwolle Myocardial Infarction Study Group. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade. Circulation 1998;97:2302-6.
45. Gibson CM, Cannon CP, Murphy SA, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000;101:125-30.